Balancing innovation and risk: artificial intelligence in travel medicine

Tropical Diseases, Travel Medicine and Vaccines · Published 2026-07-01 · DOI 10.1186/s40794-026-00309-z

Free full text

Authors (1)

Perry J. J. van Genderen

Abstract

Abstract Artificial intelligence (AI) is increasingly influencing travel medicine, a field traditionally reliant on expert judgement and static guidelines. Machine learning systems, generative AI models and digital surveillance tools have the potential to enhance pre-travel counselling, improve diagnostic pathways and strengthen outbreak detection. However, concerns remain regarding variable performance, data privacy and the absence of clear regulatory frameworks. This Perspective examines the role of AI across the travel health continuum, highlighting both opportunities and limitations. Rather than replacing clinical expertise, AI should be carefully validated and integrated to support decision-making. Responsible implementation could improve access, personalize care and strengthen global health security.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2026

Citation

Genderen, P. (2026). Balancing innovation and risk: artificial intelligence in travel medicine. Tropical Diseases, Travel Medicine and Vaccines. https://doi.org/10.1186/s40794-026-00309-z

Related articles